A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

Objective. Iron isomaltoside 1000 (Monofer®) is a high-dose intravenous (IV) iron, which in a recent 8 weeks trial in inflammatory bowel disease (IBD) subjects with iron deficiency anemia (IDA) demonstrated good tolerability and efficacy. The present trial is an extension to this trial, which evalua...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Scand J Gastroenterol
Main Authors: Reinisch, Walter, Altorjay, Istvan, Zsigmond, Ferenc, Primas, Christian, Vogelsang, Harald, Novacek, Gottfried, Reinisch, Sieglinde, Thomsen, Lars L.
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2015
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673551/
https://ncbi.nlm.nih.gov/pubmed/25900645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00365521.2015.1031168
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki